News Conference News ESC 2012 ESC Congress 2012 Offers Slate of Guidelines, New MI Definition Caitlin E. Cox August 26, 2012
News Conference News EuroPCR 2012 EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage Caitlin E. Cox May 22, 2012
News Conference News EuroPCR 2012 Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR Jason Kahn May 16, 2012
News Conference News EuroPCR 2012 Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible Caitlin E. Cox May 16, 2012
News Conference News EuroPCR 2012 FAME II: FFR Pinpoints Stable CAD Patients Who Need PCI in Addition to Medical Therapy Caitlin E. Cox May 15, 2012
News Conference News Study Examines Influence of Baseline Factors on Outcomes After CABG, PCI L.A. McKeown May 11, 2012
News Conference News SCAI 2012 MOBILITY Supports Iliac Stenting in Extensive PAD Cases Caitlin E. Cox May 11, 2012
News Conference News ACC 2012 ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released Yael L. Maxwell April 02, 2012
News Conference News ACC 2012 ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease Yael L. Maxwell March 27, 2012
News Conference News ACC 2012 BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy Jason Kahn March 25, 2012
News Conference News ACC 2012 Three Months of Antiplatelet Therapy with Endeavor Equal to 1 Year with Other DES Jason Kahn March 24, 2012
News Conference News ACC 2012 New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding L.A. McKeown March 24, 2012
News Conference News Cell Therapy 2012 Novel Strategies Advance Cell Therapy for Cardiomyopathy February 05, 2012
News Conference News Cell Therapy 2012 Expedited Cell Therapy After STEMI Shows Promise January 29, 2012
News Conference News Adenosine-Free Pressure Measurement Found Equivalent to FFR L.A. McKeown December 01, 2011
News Conference News COBRA: Postdilation with Cryoplasty Reduces Restenosis in Diabetic SFA Lesions Jason Kahn November 30, 2011
News Conference News TWENTE: Zotarolimus DES Noninferior to Everolimus DES at 1 Year L.A. McKeown November 28, 2011
News Conference News RIBS III: Alternative DES Best Bet for DES In-Stent Restenosis November 22, 2011
News Conference News Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version November 20, 2011
News Conference News Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes November 16, 2011